Inhibitors of human immunodeficiency virus
AssigneeIsis Pharmaceuticals, Inc.
InventorsDavid J. Ecker, Jacqueline R. Wyatt, Jean L. Imbach
Life of this patent
Estimating the term…
Abstract
The phosphorothioate oligonucleotide T.sub.2 G4T2 was identified as an inhibitor of HIV infection in vitro by combinatorial screening of a library of phosphorothioate oligonucleotides that contained all possible 8-nucleotide sequences. The oligonucleotide forms a parallel-stranded tetrameric guanosinequartet (G-quartet) structure. Tetramer formation and the phosphorothioate backbone are essential for antiviral activity. The G-quartet structure binds to the HIV envelope protein gp120 at the V3 loop and inhibits both cell-to-cell and virus-to-cell infection.
Claims1
An oligonucleotide TTGGGGTT wherein at least one linkage is a phosphorothioate.
Dependencies are inferred from the claim text.